[{"address1": "123 West Nye Lane", "address2": "Suite 446", "city": "Carson City", "state": "NV", "zip": "89706", "country": "United States", "phone": "844 238 2692", "website": "https://cellmedx.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Yanika  Silina C.M.A., CPA", "age": 45, "title": "CFO, Treasurer, Corporate Secretary & Director", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 30000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bradley S. Hargreaves", "age": 64, "title": "VP of Technology & Operations and Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 32206, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. George  Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.", "age": 71, "title": "MD & Independent Director", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. Jeffs", "age": 53, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.028, "open": 0.043, "dayLow": 0.043, "dayHigh": 0.043, "regularMarketPreviousClose": 0.028, "regularMarketOpen": 0.043, "regularMarketDayLow": 0.043, "regularMarketDayHigh": 0.043, "beta": 31.04, "volume": 2000, "regularMarketVolume": 2000, "averageVolume": 76015, "averageVolume10days": 61133, "averageDailyVolume10Day": 61133, "marketCap": 12673648, "fiftyTwoWeekLow": 0.0002, "fiftyTwoWeekHigh": 0.9312, "priceToSalesTrailing12Months": 42816.38, "fiftyDayAverage": 0.026364, "twoHundredDayAverage": 0.0277155, "currency": "USD", "enterpriseValue": 13684221, "floatShares": 100130788, "sharesOutstanding": 294736000, "heldPercentInsiders": 0.56058, "impliedSharesOutstanding": 62923100, "bookValue": -0.04, "lastFiscalYearEnd": 1685491200, "nextFiscalYearEnd": 1717113600, "mostRecentQuarter": 1701302400, "netIncomeToCommon": -335044, "trailingEps": -0.01, "enterpriseToRevenue": 46230.477, "52WeekChange": 0.48275864, "SandP52WeekChange": 0.20347583, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "CMXC", "underlyingSymbol": "CMXC", "shortName": "CELL MEDX CORP", "longName": "Cell MedX Corp.", "firstTradeDateEpochUtc": 1377783000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ed5dcc97-7b50-370b-8d31-a79c6641f3f3", "messageBoardId": "finmb_109365964", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.043, "recommendationKey": "none", "totalCash": 22623, "totalDebt": 1033180, "quickRatio": 0.009, "currentRatio": 0.009, "totalRevenue": 296, "returnOnAssets": -7.04153, "freeCashflow": -146348, "operatingCashflow": -204673, "grossMargins": 0.81081, "operatingMargins": -892.6385, "financialCurrency": "USD", "trailingPegRatio": null}]